Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer
Clinical trial NCT02826772 · COMPLETED
Trial details
- NCT number
- NCT02826772
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-10
- Primary completion
- 2019-05-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.